[Progress of clinical trials on breast cancer in China, 2011-2022].
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Substantial achievements have been made in the development of new breast cancer drugs in China from 2011 to 2022. However, there remains a significant gap in the innovation capabilities of domestic pharmaceutical companies compared to international counterparts in the field of breast cancer. Future efforts should be directed towards strengthening research and development in breast cancer, exploring new target points, and investigating combination therapy mechanisms.
Fields of Study & Subjects
Breast Cancer Treatment Studies
Advanced Breast Cancer Therapies
Cancer Treatment and Pharmacology
Publication details
- Journal / source
- PubMed
- Volume
- 48
- Issue
- 3
- Pages
- 445–450
- Publication date
- 23 March 2026
- Language
- ZH